Affiliation:
1. Department of Virology, Faculty of Biology, Lomonosov Moscow State University
Abstract
The present work is concerned with development of recombinant antigen for the vaccine prototype. The vaccine is going to be effective against a wide range of rotaviruses. Antigen VP8+875x6 was developed on the basis of VP8 protein. It also includes several neutralizing epitopes from rotaviral proteins VP8, VP5 and VP7.
Funder
Russian Foundation for Basic Research
Publisher
CO LTD "EXPO-BIOHIM-TEXNOLOGIES"